New Developments in Electroconvulsive Therapy and Magnetic Seizure Therapy

CNS Spectrums

Volumn 8, Issue 7, 2003, Pages 529-536

  Lisanby, Sarah H ^a,b   Morales, Oscar ^a,b   Payne, Nancy ^b   Kwon, Edward ^b   Fitzsimons, Linda ^b   Luber, Bruce ^a,b   Nobler, Mitchell S ^a,b   Sackeim, Harold A ^a,b  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; METHOHEXITAL; NORTRIPTYLINE; SUXAMETHONIUM;

CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEVICE; ELECTROCARDIOGRAM; ELECTROCONVULSIVE THERAPY; ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROSTIMULATION; GENERAL ANESTHESIA; HIPPOCAMPUS; HUMAN; INTERMETHOD COMPARISON; MAGNETIC FIELD; MAGNETIC SEIZURE THERAPY; MAJOR DEPRESSION; MOSSY FIBER; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; RELAPSE; REVIEW; SEIZURE; TASK PERFORMANCE; TECHNIQUE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; ANIMAL; MAGNETISM; METHODOLOGY; PHYSIOTHERAPY;

ANIMALS; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; MAGNETICS; PHYSICAL THERAPY MODALITIES; TREATMENT OUTCOME;

EID: 0141670273     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900019003     Document Type: Review

References (83)

1. Sackeim HA. Magnetic stimulation therapy and ECT. Convuls Ther. 1994;10:255-258.
2. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensifies. Arch Gen Psychiatry. 2000;57:425-434.
3. Sackeim HA, Haskett RF, Mulsant BH et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299-1307.
4. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 2001;25:836-844.
5. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000;20:9104-9110.
6. Kempermann G. Regulation of adult hippocampal neurogenesis-implications for novel theories of major depression. Bipolar Disord. 2002;4:17-33.
7. Duman RS, Malberg J, Nakagawa S, D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry. 2000;48:732-739.
8. Jacobs BL, Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry. 2000;5:262-269.
9. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry. 2000;47:1043-1049.
10. Segman RH, Shapira B, Gorfine M, Lerer B. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology (Berl). 1995;119:440-448.
11. Nobler MS, Sackeim HA, Moeller JR, Prudic J, Petkova E, Waternaux C. Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods. Convuls Ther. 1997;13:208-2021.
12. Scott BW, Wojtowicz JM, Burnham WM. Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp Neurol. 2000;165:231-236.
13. Hellsten J, Wennstrom M, Mohapel P, Ekdahl CT, Bengzon J, Tingstrom A. Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment. Eur J Neurosci. 2002;16:283-290.
14. Steward O, Cotman CW, Lynch GS. Re-establishment of electrophysiologically functional entorhinal cortical input to the dentate gyrus deafferented by ipsilateral entorhinal lesions: innervation by the contralateral entorhinal cortex. Exp Brain Res. 1973;18:396-414.
15. Tauck DL, Nadler JV. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J Neurosci. 1985;5:1016-1022.
16. Vaidya VA, Duman RS. Depression-emerging insights from neurobiology. Br Med Bull. 2001;57:61-79.
17. Vaidya VA, Siuciak JA, Du F, Duman RS. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience. 1999;89:157-166.
18. Lisanby SH, Arango V, Underwood MD, Perara T, Dwork AJ, Sackeim HA. Hippocampal plasticity following chronic repetitive transcranial magnetic stimulation [abstract]. J ECT. 2000;16:74-75.
19. Duman RS, Malberg J, Thome J. Neural plasticity to stress and antidepressant treatment. Biol Psychiatry. 1999;46:1181-1191.
20. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995; 15:7539-7547.
21. Lisanby SH, Sackeim HA, Dwork A, et al. Effects of electrically- and magnetically-induced seizures on synaptic remodeling and cellular proliferation in the primate hippocampus. Abstract presented at: Annual Meeting of the American College of Neuropsychopharmacology; San Juan, Puerto Rico; December 11, 2002.
22. Lisanby SH, Sackeim HA, Dwork A, et al. Effects of electroconvulsive shock and magnetic seizure therapy on mossy fiber sprouting and cellular proliferation in the primate hippocampus. Biol Psychiatry. 2003;53:173S.
23. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328:839-846.
24. Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry. 1987;144:1449-1455.
25. Ng C, Schweitzer I, Alexopoulos P, et al. Efficacy and cognitive effects of right unilateral electroconvulsive therapy. J ECT. 2000;16:370-379.
26. Sackeim HA, Decina P, Prohovnik I, Portnoy S, Kanzler M, Malitz S. Dosage, seizure threshold, and the antidepressant efficacy of electroconvulsive therapy. Ann N Y Acad Sci. 1986;462:398-410.
27. McCall WV, Reboussin DM, Weiner RD, Sackeim HA. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry. 2000;57:438-444.
28. Sackeim HA. Acute cognitive side effects of ECT. Psychopharm Bull. 1986;22:482-484.
29. Lisanby SH, Maddox JH, Prudic J, Devanand DP, Sackeim HA. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry. 2000;57:581-590.
30. Sackeim HA, Luber B, Moeller JR, Prudic J, Devanand DP. Nobler MS. Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. J ECT. 2000;16:110-120.
31. Weiner RD, Rogers HJ, Davidson JR, Squire LR. Effects of stimulus parameters on cognitive side effects. Ann NY Acad Sci. 1986;462:315-325.
32. Sackeim HA, Long J, Luber B et al. Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther. 1994;10:93-123.
33. Swartz CM, Larson G. ECT stimulus duration and its efficacy. Ann. Clin Psychiatry. 1989;1:147-152.
34. Devanand DP, Lisanby SH, Nobler MS, Sackeim HA. The relative efficiency of altering pulse frequency or train duration when determining seizure threshold. J ECT. 1998;14:227-235.
35. Yuen GH, Agnew WF, Bullara LA, Jacques S, McCreery DB. Histological evaluation of neural damage from electrical stimulation: considerations for the selection of parameters for clinical application. Neurosurgery. 1981;9:292-299.
36. Ranck JB. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res. 1975;98:417-440.
37. Ronner SF. Electrical excitation of CNS neurons. In: Agnew WF, McCreery DB, eds. Neural Prostheses: Fundamental Studies. Englewood Cliffs, NJ: Prentice Hall; 1990.
38. McCreery DB, Agnew WF, Yuen TGH, Bullara L. Charge density and charge per phase as cofactors in neural injury induced by electrical stimulation. IEEE Trans Biomed Eng. 1990;37:996-1001.
39. Woodbury LA, Davenport VD. Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern. Arch Int Pharmacodyn. 1952;92:97-107.
40. Hyrman V, Palmer LH, Cernik J, Jetelina J. ECT: the search for the perfect stimulus. Biol Psychiatry 1985;20:634-645.
41. Liberson WT. Brief stimulus therapy: physiological and clinical observations. Am J Psychiatry. 1948;105:28-29.
42. Goldman D. Brief stimulus electric shock therapy. J Nerv Ment Dis. 1949;110:36-45.
43. Cronholm B, Ottoson JO. Ultrabrief stimulus technique in electroconvulsive therapy. II. Comparative studies of therapeutic effects and memory disturbances in treatment of endogenous depression with the Elther ES electroshock apparatus and Siemens Konvulsator III. J Nerv Ment Dis. 1963;137:268-276.
44. Cronholm B, Ottosson JO. Ultrabrief stimulus technique in electroconvulsive therapy. I. Influence on retrograde amnesia of treatments with the Elther ES electroshock apparatus, Siemens Konvulsator III and of lidocane-modified treatment. J Nerv Ment Dis. 1963;137:117-123.
45. Valentine M, Keddie KM, Dunne D. A comparison of techniques in electroconvulsive therapy. Br J Psychiatry. 1968;114:989-996.
46. Robin A, De Tissera S. A double-blind controlled comparison of the therapeutic effects of low and high energy electroconvulsive therapies. Br J Psychiatry. 1982;141:357-366.
47. Lisanby S, Luber B, Osman M, et al. The effect of pulse width on seizure threshold during electroconvulsive shock (ECS). Convul Ther. 1997;13:56.
48. Sackeim HA, Prudic J, Nobler MS, Lisanby SH, Devanand DP. Peyser S. Ultra-brief pulse ECT and the affective and cognitive consequences of ECT. J ECT. 2001;17:77.
49. Nobler MS, Sackeim HA, Prohovnik I, et al. Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Arch Gen Psychiatry, 1994;51:884-897.
50. Awata S, Konno M, Kawashima R, et al. Changes in regional cerebral blood flow abnormalities in late-life depression following response to electroconvulsive therapy. Psychiatry. Clin Neurosci. 2002;56:31-40.
51. Nobler MS, Oquendo MA, Kegeles LS, Campbell C, Sackeim HA, Mann JJ. Decreased regional brain metabolism after ECT. Am J Psychiatry. 2001;158:305-308.
52. Henry ME, Schmidt ME, Matochik JA, Stoddard EP, Potter WZ. The effects of ECT on brain glucose: a pilot FDG PET study. J ECT. 2001;17:33-40.
53. Sackeim HA, Luber B, Katzman GP, et al. The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry. 1996;53:814-824.
54. Luber B, Nobler MS, Moeller JR, et al. Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. II. Topographic analyses. J ECT. 2000;16:229-243.
55. Heath RG, Norman EC. Electroshock therapy by stimulation of discrete cortical siteswith small electrodes. Proc Soc Exp Biol Med. 1946;63:496-502.
56. Swartz CM. Asymmetric bilateral right frontotemporal left frontal stimulus electrode placement for electroconvulsive therapy. Neuropsychobiology. 1994;29:174-178.
57. Bailine SH, Rifkin A, Kayne E, et al. Comparison of bifrontal and bitemporal ECT for major depression. Am J Psychiatry. 2000;157:121-123.
58. Letemendia FJ, Delva NJ, Rodenburg M, et al. Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med. 1993;23:349-360.
59. Heikman P, Kalska H, Katila H, Sarna S, Tuunainen A, Kuoppasalmi K. Right unilateral and bifrontal electroconvulsive therapy in the treatment of depression: a preliminary study. J ECT. 2002;18:26-30.
60. Epstein CM. Localizing the site of magnetic brain stimulation in humans. Neurol. 1990;40:666-670.
61. George MS, Lisanby SH, Sackeim HA. Transcranial magnetic stimulation: applications in neuropsychaitry. Arch Gen Psychiatry. 1999;56:300-311.
62. Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol. 2001;112:1367-1377.
63. Lisanby SH, Sackeim HA. TMS in major depression. In: George MS, Belmaker RH, eds. Transcranial Magnetic Stimulation (TMS): Applications in Neuropsychiatry. Washington, DC: American Psychiatric Press; 2000:185-200.
64. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta-analysis. Int J Neuropsychopharmacol. 2002;5:73-103.
65. Martin JL, Barbanoj MJ, Schlaepfer TE, et al. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev. 2002;(2):CD003493.
66. Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry. 2000;47:314-324.
67. Janicak PG, Dowd SM, Martis B, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry. 2002;51:659-667.
68. Lisanby SH, Luber B, Finck AD, Schroeder C, Sackeim HA. Deliberate seizure induction with repetitive transcranial magnetic stimulation. Arch Gen Psychiatry. 2001;58:199-200.
69. Lisanby SH, Luber BM, Finck D, Osman M, Schroeder C, Sackeim HA. Magnetic stimulation therapy: a novel convulsive technique. Biol Psychiatry. 1999;45:64S-65S.
70. Weissman JD, Epstein CM, Davey KR. Magnetic brain stimulation and brain size: relevance to animal studies. Electroencephalogr Clin Neurophysiol. 1992;85:215-219.
71. Lisanby SH, Gutman D, Luber B, Schroeder C, Sackeim HA. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry. 2001;49:460-463.
72. Lisanby SH, Luber B, Schroeder C, et al. Intracerebral measurement of rTMS and ECS induced voltage in vivo. Biol Psychiatry. 1998;43(suppl):100S.
73. Lisanby SH, Luber BL, Schroeder C, et al. rTMS in primates: intracerebral measurement of rTMS and ECS induced voltage in vivo. Electroencephalogr Clin Neurophysiol. 1998;107(suppl):79P.
74. Lisanby SH, Schlaepfer TE, Fisch H-U, Sackeim HA. Magnetic seizure induction for the treatment of major depression. Arch Gen Psychiatry. 2001;58:303-305.
75. Pascual-Leone A, Cohen LG, Shotland LI, et al. No evidence of hearing loss in humans due to transcranial magnetic stimulation. Neurology. 1992;42:647-651.
76. Roth BJ, Pascual-Leone A, Cohen LG, Hallet M. The heating of metal electrodes during rapid-rate magnetic stimulation: a possible safety hazard. Electroencephal Clin Neurophysiol. 1992;85:116-123.
77. Lisanby SH, Luber B, Barroilhet L, Neufeld E, Schlaepfer T, Sackeim HA. Magnetic seizure therapy (MST): acute cognitive effects of MST compared with ECT [abstract]. J ECT. 2001;17:77.
78. Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology. 2003; In press.
79. Lisanby SH, Devanand DP, Nobler MS, Prudic J, Mullen L, Sackeim HA. Exceptionally high seizure threshold: ECT device limitations. Convuls Ther. 1996;12:156-164.
80. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry. 1993;34:321-330.
81. Folkerts H. The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci. 1996;246:155-164.
82. Krystal AD, Weiner RD, Coffey CE. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. J Neuropsychiatry Clin Neurosci. 1995;7:295-303.
83. Suppes T, Webb A, Carmody T, et al. Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affect Disord. 1996;41:55-58.